These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21996921)

  • 1. Influenza vaccine 2011-2012.
    Med Lett Drugs Ther; 2011 Oct; 53(1375):81-3. PubMed ID: 21996921
    [No Abstract]   [Full Text] [Related]  

  • 2. New vaccine approaches for seasonal and pandemic influenza.
    Palache B
    Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccination in Europe--still a long way to go.
    Ruef C
    Infection; 2007 Oct; 35(5):299. PubMed ID: 17885727
    [No Abstract]   [Full Text] [Related]  

  • 4. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of inactivated influenza vaccine in children.
    Wright PF
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons.
    Katayose M; Hosoya M; Haneda T; Yamaguchi H; Kawasaki Y; Sato M; Wright PF
    Vaccine; 2011 Feb; 29(9):1844-9. PubMed ID: 21195802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against influenza and pneumococcal disease--are we doing our best?
    Morris A; Lang SD
    N Z Med J; 1989 Apr; 102(866):193-5. PubMed ID: 2710448
    [No Abstract]   [Full Text] [Related]  

  • 8. Pre- or post-pandemic influenza vaccine?
    Osterhaus AD
    Vaccine; 2007 Jun; 25(27):4983-4. PubMed ID: 17555851
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influenza vaccination: NOW!].
    Heinzl S
    Med Monatsschr Pharm; 2006 Nov; 29(11):389. PubMed ID: 17131684
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the reactivity, safety and immunogenicity of the polyvalent subunit "Grippovak SE-Azh" influenza vaccine in boarding houses for the elderly and disabled].
    Beregovskiĭ NA; Malyshkina LP; Serdiukova LP; Belousova NI; Velikiĭ VN
    Vestn Akad Med Nauk SSSR; 1985; (1):9-12. PubMed ID: 3156457
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis.
    Villari P; Manzoli L; Boccia A
    Vaccine; 2004 Sep; 22(25-26):3475-86. PubMed ID: 15308375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study suggests influenza vaccination during pregnancy protects newborns.
    Constable L
    Expert Rev Vaccines; 2011 Aug; 10(8):1117. PubMed ID: 21961198
    [No Abstract]   [Full Text] [Related]  

  • 15. 'Reverse genetics' could offer forward-thinking flu vaccine.
    Pearson H
    Nature; 2003 Dec; 426(6968):742. PubMed ID: 14685181
    [No Abstract]   [Full Text] [Related]  

  • 16. Influenza vaccines: the good, the bad, and the eggs.
    Schultz-Cherry S; Jones JC
    Adv Virus Res; 2010; 77():63-84. PubMed ID: 20951870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of split-product trivalent influenza vaccine in high-risk children.
    Yamada A; Yamawaki H; Tsuda N; Baba K; Yabuuchi H; Maeda A; Yamanishi K
    Biken J; 1982 Jun; 25(2):89-95. PubMed ID: 6753829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficiency of "Vaxigrip" vaccine in the complex immunization of servicemen].
    Burtseva EI; Rikhter VV; Sabanin IuV; Slepushkin AN; Vlasova LN; Shevchenko ES; Artiukov PM; Rybin VV; Tarasevich NN
    Voen Med Zh; 2003 Oct; 324(10):41-5. PubMed ID: 14671894
    [No Abstract]   [Full Text] [Related]  

  • 19. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.
    Herrera GA; Iwane MK; Cortese M; Brown C; Gershman K; Shupe A; Averhoff F; Chaves SS; Gargiullo P; Bridges CB
    Vaccine; 2007 Jan; 25(1):154-60. PubMed ID: 17064823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCVID patients may not respond to influenza immunization.
    Sewell WA
    Clin Immunol; 2005 Feb; 114(2):210; author reply 211. PubMed ID: 15639655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.